Nachman Norwood & Parrott’s Guardant Health GH Stock Holding History

Nachman Norwood & Parrott’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-235	Closed	-$26K	–	555
2020 Q3	$26K	Buy	+235	New	+$21.5K	﹤0.01%	568

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Nachman Norwood & Parrott's GH Position: Q4 2020 in Review

Nachman Norwood & Parrott sold out of Guardant Health (GH) in Q4 2020, closing a stake of 235 shares — an estimated $26K sold.

Nachman Norwood & Parrott first reported a position in GH in Q3 2020 and held it in 1 quarter. The position peaked at $26K in Q3 2020. 419 funds tracked by Wall St. Rank hold GH as of Q4 2020.

Nachman Norwood & Parrott reported no remaining Guardant Health position as of Q4 2020 after selling out during the quarter.
Nachman Norwood & Parrott sold 235 Guardant Health shares in Q4 2020, an estimated $26K.
Nachman Norwood & Parrott first reported a position in Guardant Health in Q3 2020 and held it in 1 quarter.
Nachman Norwood & Parrott's Guardant Health position peaked at $26K in Q3 2020.
419 funds tracked by Wall St. Rank held Guardant Health as of Q4 2020.

Based on Nachman Norwood & Parrott's 13F filing for Q4 2020, filed 19 Jan 2021.